Biotech

All Articles

Analysts examine Avidity's DMD succeed, revealing distinctions in records

.Avidity Biosciences satisfied financiers along with phase 1/2 information in Duchenne muscle dystro...

Actinogen's cortisol blocker neglects period 2 anxiety research study

.Actinogen Medical's cortisol blocker has overlooked the key endpoint of a period 2 research study i...

Bivictrix decides going private only means to take ADC in to clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG leadings up funds to $580M for investments around life scientific researches

.Resource manager TPG, which has sustained biotechs like Sionna Rehabs and also Santa Clam Ana Biogr...

Merck stops phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT system has actually suffered one more misfortune. Months after shuttering a ...

After a tough year, Exscientia folds up right into Recursion

.After a year defined by pipeline cuts, the variation of its CEO and unemployments, Exscientia will ...

Cullinan, after $25M offer, hands back bispecific to Harbour

.Cullinan Rehab was actually wowed enough with Port BioMed's bispecific immune system activator that...

A deeper examine Intense Biotech's Strong 15

.Within this full week's incident of "The Best Line," our company're diving into Brutal Biotech's ye...

Lilly faces stage 2 failure of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's celebration commemorating the approval of Alz...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and ...